Tuesday , 14 January 2025
Home biotech stocks

biotech stocks

Media

Moderna Stock Plunges as Company Slashes 2025 Revenue Forecast and Announces Major Cost Cuts

Moderna (NASDAQ: MRNA) shares tumbled 18% in premarket trading on Monday after the biotechnology company significantly lowered its 2025 revenue forecast and announced...